|
|
|
Insider
Information: |
Loh Evan |
Relationship: |
|
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
16,163 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$139,773 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
16,163 |
|
|
Total
Value |
$139,773 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
52.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Paratek Pharmaceuticals Inc |
PRTK |
CEO, Director |
2023-09-21 |
0 |
2014-10-30 |
0 |
Premium* |
|
Alpine Immune Sciences Inc |
ALPN |
Director |
2015-06-16 |
2,163 |
|
0 |
Premium* |
|
Celladon Corp |
CLDN |
|
2022-03-11 |
14,000 |
2020-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2023-09-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,327,981) |
0 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2023-08-09 |
4 |
S |
$2.20 |
$107,727 |
D/D |
(48,967) |
1,327,981 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2023-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
168,750 |
1,376,948 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2022-12-21 |
4 |
AS |
$1.99 |
$46,743 |
D/D |
(23,489) |
1,208,198 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2022-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
52,500 |
1,231,687 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2022-12-13 |
4 |
AS |
$1.96 |
$121,361 |
D/D |
(61,919) |
1,179,187 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2022-12-12 |
4 |
AS |
$1.98 |
$74,905 |
D/D |
(37,831) |
1,241,106 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2022-10-28 |
4 |
AS |
$3.47 |
$30,553 |
D/D |
(8,805) |
1,278,937 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2022-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
1,287,742 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2022-08-09 |
4 |
AS |
$2.66 |
$118,421 |
D/D |
(44,519) |
1,257,742 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2022-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
152,727 |
1,302,261 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2022-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
236,250 |
1,149,534 |
0 |
- |
|
CLDN |
Celladon Corp |
|
|
2022-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
14,000 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2021-12-15 |
4 |
AS |
$4.27 |
$210,336 |
D/D |
(49,259) |
913,284 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2021-12-14 |
4 |
AS |
$4.37 |
$104,155 |
D/D |
(23,834) |
962,543 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2021-12-13 |
4 |
AS |
$4.42 |
$61,805 |
D/D |
(13,983) |
986,377 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2021-08-17 |
4 |
AS |
$5.12 |
$173,727 |
D/D |
(33,931) |
1,000,360 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2021-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
1,034,291 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2021-06-04 |
4 |
AS |
$9.70 |
$355,544 |
D/D |
(36,654) |
959,291 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2021-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
91,636 |
995,945 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2021-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
303,750 |
904,309 |
0 |
- |
|
CLDN |
Celladon Corp |
Director |
|
2021-03-15 |
4 |
S |
$10.14 |
$20,280 |
D/D |
(2,000) |
8,000 |
0 |
- |
|
CLDN |
Celladon Corp |
Director |
|
2021-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,000 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2020-12-14 |
4 |
AS |
$6.71 |
$177,245 |
D/D |
(26,415) |
600,559 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
CEO |
|
2020-12-11 |
4 |
AS |
$6.95 |
$129,166 |
D/D |
(18,585) |
626,974 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|